炎症-衰弱指数的开发与验证:肾移植中的应用
该研究在1154例肾移植候选者和受者中,将炎症生物标志物(IL6、TNFα、CRP)分别作为第六个组分加入传统身体衰弱表型,构建炎症-衰弱指数。潜类别分析支持二分类(衰弱 vs 非衰弱)模型。
要点
- IL6-衰弱与肾移植后死亡率升高独立相关(校正后风险比2.07)。
- TNFα-衰弱与CRP-衰弱与死亡率无显著关联。
- 炎症-衰弱指数未改善对肾移植后死亡风险的预测。
核心结论
- 移植时测量IL6-衰弱有助于识别应接受移植前干预的患者。
- 传统身体衰弱表型足以用于肾移植后死亡风险预测。
研究设计与样本
- 研究纳入2个移植中心2009-2017年的1154例肾移植候选者和受者,均具有身体衰弱表型和炎症指标(IL6、TNFα、CRP)数据。
- 采用潜类别分析评估炎症-衰弱指数的结构效度。
- 炎症-衰弱指数将5个身体衰弱表型组分分别与单个炎症标志物(最高三分位)组合作为第六个组分。
- 使用Kaplan-Meier法和校正Cox比例风险模型评估肾移植后死亡风险(n=378)。
- 使用Harrell C统计量评估风险预测的区分度。
主要发现
- 基于拟合标准,二分类(衰弱 vs 非衰弱)模型对炎症-衰弱指数拟合最佳。
- IL6-衰弱组与非衰弱组的5年生存率分别为81%和93%。
- CRP-衰弱组与非衰弱组的5年生存率分别为87%和89%。
- TNFα-衰弱组与非衰弱组的5年生存率分别为83%和91%。
关键数值与推荐
- CRP-衰弱与死亡率关联的校正风险比为1.02(95%CI 0.52-2.03,p=0.95)。
- 所有炎症-衰弱指数的C统计量均为0.71,传统身体衰弱表型的C统计量为0.70。
临床怎么用
- 对于肾移植候选者,可在移植前测量IL6-衰弱以识别能从移植前干预中获益的高风险患者。
- 传统身体衰弱表型仍是肾移植后死亡风险预测的充分工具,无需常规加入炎症标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physical frailty phenotype is characterized by decreased physiologic reserve to stressors and associated with poor outcomes, such as delirium and mortality, that may result from post-kidney transplant (KT) inflammation. Despite a hypothesized underlying pro-inflammatory state, conventional measures of frailty typically do not incorporate inflammatory biomarkers directly. Among KT candidates and recipients, we evaluated the inclusion of inflammatory biomarkers with traditional physical frailty phenotype components. METHODS: Among 1154 KT candidates and recipients with measures of physical frailty phenotype and inflammation (interleukin 6 [IL6], tumor necrosis factor alpha [TNFα], C-reactive protein [CRP]) at 2 transplant centers (2009-2017), we evaluated construct validity of inflammatory-frailty using latent class analysis. Inflammatory-frailty measures combined 5 physical frailty phenotype components plus the addition of an individual inflammatory biomarkers, separately (highest tertiles) as a sixth component. We then used Kaplan-Meier methods and adjusted Cox proportional hazards to assess post-KT mortality risk by inflammatory-frailty (n = 378); Harrell's C-statistics assessed risk prediction (discrimination). RESULTS: Based on fit criteria, a 2-class solution (frail vs nonfrail) for inflammatory-frailty was the best-fitting model. Five-year survival (frail vs nonfrail) was: 81% versus 93% (IL6-frailty), 87% versus 89% (CRP-frailty), and 83% versus 91% (TNFα-frailty). Mortality was 2.07-fold higher for IL6-frail recipients (95% CI: 1.03-4.19, p = .04); there were no associations between the mortality and the other inflammatory-frailty indices (TNFα-frail: 1.88, 95% CI: 0.95-3.74, p = .07; CRP-frail: 1.02, 95% CI: 0.52-2.03, p = .95). However, none of the frailty-inflammatory indices (all C-statistics = 0.71) improved post-KT mortality risk prediction over the physical frailty phenotype (C-statistics = 0.70). CONCLUSIONS: Measurement of IL6-frailty at transplantation can inform which patients should be targeted for pre-KT interventions. However, the traditional physical frailty phenotype is sufficient for post-KT mortality risk prediction.
引用
- Haugen CE, Gross A, Chu NM, et al. Development and Validation of an Inflammatory-Frailty Index for Kidney Transplantation. J Gerontol A Biol Sci Med Sci. 2021. PMID: 32619229. doi:10.1093/gerona/glaa167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。